Sulzer rejects $2.6 billion shareholder bid to take charge
This article was originally published in Clinica
Executive Summary
Sulzer Medica's parent company has emphatically rejected an attempt by the Swiss conglomerate's largest shareholder to take over the company in order to float the medical business. Last Friday, Sulzer once again set out its own plans, dismissing the offer as "clearly too low".